Back to results
US 2014/0227307 A1Published application
Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response
AssigneeGenocea Biosciences, Inc.
InventorsDeborah Long, Jessica Flechtner, Mojca Skoberne, George R. Siber
Life of this patent
Estimating the term…
Abstract
Herpes Simplex Virus-2 (HSV-2) infection is a major health concern. The present disclosure provides, inter alia, certain highly effective vaccines and immunogenic compositions against HSV-2. The antigens can be used therapeutically or prophylactically.
Claims28
-6. (canceled)
A vaccine formulation comprising a pharmaceutically acceptable carrier, an adjuvant comprising one or more purified fractions of quillaja saponins, and at least one polypeptide comprising any of SEQ ID NOS:
- 2, 3, 4 and 5 or an immunogenic fragment thereof, and optionally further comprising SEQ ID NO:1 or an immunogenic fragment thereof.
8-15. (canceled)
17-18. (canceled)
(canceled)
(canceled)
(canceled)
(canceled)
41-42. (canceled)
Dependencies are inferred from the claim text.